The in vivo potency and selectivity of azelastine as an H1 histamine-receptor antagonist in human airways and skin
Open Access
- 1 December 1988
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 82 (6) , 1113-1118
- https://doi.org/10.1016/0091-6749(88)90151-0
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Pharmacodynamic evaluation of azelastine in subjects with asthmaJournal of Allergy and Clinical Immunology, 1987
- A dose-response study of the bronchodilator action of azelastine in asthmaJournal of Allergy and Clinical Immunology, 1987
- The effect of single and multiple dose therapy with azelastine on the immediate asthmatic response to allergen provocation testingJournal of Allergy and Clinical Immunology, 1986
- 251 Azelastine (azel) in the treatment of asthmaJournal of Allergy and Clinical Immunology, 1985
- Inhibition by azelastine of nonallergic histamine release from rat peritoneal mast cellsJournal of Allergy and Clinical Immunology, 1984
- Inhibition of calcium ionophore (A23187)-stimulated histamine release from rat peritoneal mast cells by azelastine: Implications for its mode of actionEuropean Journal of Pharmacology, 1983
- Effect of an H1 Blocker, Chlorpheniramine, on Inhalation Tests with Histamine and Allergen in Allergic AsthmaChest, 1980
- Bronchodilatation after inhalation of the antihistamine clemastine.Thorax, 1978
- Bronchodilating activity of an H blocker, chlorpheniramineJournal of Allergy and Clinical Immunology, 1977
- Standardization of bronchial inhalation challenge proceduresJournal of Allergy and Clinical Immunology, 1975